Parcourir par sujet "CISPLATIN PLUS ETOPOSIDE"
Voici les éléments 1-1 de 1
-
Assessing the relative effectiveness and tolerability of treatments in small cell lung cancer: A network meta-analysis
(2013)Background: The combination of Cisplatin plus Etoposide (EP) is currently the standard treatment for small cell lung cancer (SCLC). However, a large number of alternative treatments (monotherapies and combinations) have ...